(NASDAQ: RXST) Rxsight's forecast annual revenue growth rate of 18.21% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.84%.
Rxsight's revenue in 2025 is $148,310,000.On average, 6 Wall Street analysts forecast RXST's revenue for 2025 to be $6,882,929,294, with the lowest RXST revenue forecast at $6,607,573,111, and the highest RXST revenue forecast at $7,701,114,269. On average, 6 Wall Street analysts forecast RXST's revenue for 2026 to be $8,365,447,635, with the lowest RXST revenue forecast at $7,678,357,560, and the highest RXST revenue forecast at $9,785,385,025.
In 2027, RXST is forecast to generate $10,020,348,049 in revenue, with the lowest revenue forecast at $8,549,614,433 and the highest revenue forecast at $11,813,983,116.